Back to Annual Meeting
Back to Annual Meeting
APHA Scientific Session and Event Listing
Katherine M. Marconi, PhD, MS, Strategic Information Staff of the Office of the Global AIDS Coordinator, Country Strategic Information Liaisons, and Strategic Information Advisors. U.S. Department of State, Office of the Global AIDS Coordinator, SA-29, 2nd Floor, Washington, DC 20522, 202-663-2537, MarconiKM@state.gov
The purpose of this presentation is to show how a strategic information approach that integrates HIV surveillance, monitoring and evaluation, and health information systems can produce standardized HIV program output and epidemic information for 15 primarily African countries. The reporting of results is mandated by The United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003 and it involves seven US government agencies: USAID, The Department of Health and Human Services, The State Department, The Department of Defense, The US Census Bureau, The Peace Corps, and The Department of Labor. Records and reports from the first three years of the President's Emergency Plan for AIDS Relief (PEPFAR) are used in the presentation. The costs and outputs of this approach are presented as well as the prevention, treatment, and care results produced by the PEPFAR supported system. From 2004 through 2009 we are tracking indicators such as the number of new infections, number of people receiving treatment, the number of orphans served and the number of women receiving Maternal to Child Transmission screening and treatment. PEPFAR is the first international HIV donor supported program to require and to use uniform results reporting requirements for planning future budget allocations. Our experience in building this reporting system has implications for both national health reporting systems and donor reporting requirements.
Keywords: HIV/AIDS, International Health
Related Web page: www.pepfar.gov
Presenting author's disclosure statement:
Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.